banner

News Releases

Keyword Search

None | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Date Title
04/21/21
 Acadia Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021
04/05/21
 Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
03/08/21
 Acadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
02/24/21
 Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
02/19/21
 Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
02/18/21
 Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
02/10/21
 Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
01/27/21
 Acadia Pharmaceuticals Announces Commercial Leadership Change